 AstraZeneca PLC on Friday rejected an improved takeover offer from Pfizer Inc worth more than  billion saying the proposal substantially undervalued the company and putting the onus back on Pfizer Chief Executive Ian Read to either raise his bid again go directly to shareholders or walk away The British company said the financial and other terms described in the US groups latest proposal were inadequate and not a basis on which to engage in talks